Paper Title
Choosing Wisely: A Comparative Analysis of Generic and Branded Anti-Hypertensive Drugs Telmisartan And Metoprolol Succinate
Article Identifiers
Authors
Saniya Dastagir Pathan , Shahin Mehboob Pathan , Dipti Vilas Sable , Swarup Manohar Harne , Dr. Wakale V.S.
Keywords
Generic drug’s , Branded drug’s , Safety , Efficacy , Affordability , Cost of therapy for generic drug’s , health policy , Scope , Objectives and Definition , Methodology , etc.
Abstract
High blood pressure, or hypertension, is a prevalent heart ailment that affects a large proportion of the world's population. High blood pressure medication is commonly used to treat the condition. Antihypertensive drugs are prescribed in medicine with both brand and generic names. The goal of this study is to compare generic and branded versions of two commonly prescribed antihypertensive drugs, telmisartan and metoprolol succinate, based on quality. This study considered a number of evaluation factors, including weight variation, weight uniformity, hardness, brittleness, disintegration, and dissolution. The use of brand-name or generic drugs has recently caused much debate on a global scale. Furthermore, the governments of a number of countries actively encourage the use of generic pharmaceuticals instead of name-brand medications. A generic drug has therapeutic efficacy similar to its brand-name counterpart and includes the same active ingredient or substances. Generic drugs are much less expensive than name-brand medications since they do not have to go through the extensive and costly preclinical or clinical trials that brand-name medications undertake, which significantly raises the cost of those prescriptions. This analysis provides an overview of the comparative effectiveness of metoprolol succinate and telmisartan generics versus name-brand drugs. The objective also attempts to draw attention to the discrepancies in prices between the two categories, as well as the laws and controls surrounding both pharmaceuticals.
Downloads
How To Cite (APA)
Saniya Dastagir Pathan , Shahin Mehboob Pathan, Dipti Vilas Sable, Swarup Manohar Harne, & Dr. Wakale V.S. (May 2024). Choosing Wisely: A Comparative Analysis of Generic and Branded Anti-Hypertensive Drugs Telmisartan And Metoprolol Succinate. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(5), I177-I189. https://ijnrd.org/papers/IJNRD2405820.pdf
Issue
Volume 9 Issue 5, May-2024
Pages : I177-I189
Other Publication Details
Paper Reg. ID: IJNRD_222839
Published Paper Id: IJNRD2405820
Downloads: 000121997
Research Area: Pharmacy
Country: Pune, Maharashtra , India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2405820.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2405820
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: October 2025
Current Issue: Volume 10 | Issue 10 | October 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Oct-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
